~~<i id='3E3EE255AC'><strike id='3E3EE255AC'><tt id='3E3EE255AC'><pre id='3E3EE255AC'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：knowledge 2025-09-28 04:05:16 Page View：996

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches
Next article： Continuity nursing helped my family in our darkest PICU moments

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

MEXICOCITY--NewlyformedHurricaneBeatrizsweptalongMexico’ssouthwesternPacificcoastlateFriday,threaten

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Brazil's Jair Bolsonaro is barred from running for office until 2030

MinisteroftheSupremeElectoralCourtCarmenLucia,right,talkswithCorregidorandMinisterRapporteurBenedito